On the AI front, I can tell you that, while it's not specific to antibiotics, we're part of a national consortium around pandemic preparedness and working on leveraging AI to be able to design vaccines that can be rapidly deployed in the case of a new pandemic. There is a very big opportunity for Canada to be able to use similar things for antibiotics.
We've seen that AI as a technology is able to be a great lever in the acceleration of new antibiotics being created. Certainly that's an incredible opportunity here in Canada.
Again, this is part of this pairing of the two. We're fortunate here to have Nobel laureate Dr. Michael Houghton. Being able to pair somebody like Mike Houghton and the expertise of the research institute that we have is going to bear really fruitful results.